Exelixis
EXEL
#1875
Rank
ยฃ8.20 B
Marketcap
ยฃ30.61
Share price
-0.39%
Change (1 day)
0.07%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Exelixis (EXEL) Fails to deliver data

Key failure to deliver metrics for Exelixis:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Exelixis (EXEL) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Exelixis (EXEL) - since 2013

Volume in USD (price x number of shares), data since 2013

Exelixis (EXEL) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026ยฃ8.49 M-65.76%
2025ยฃ24.8 M105.32%
2024ยฃ12.08 M86.29%
2023ยฃ6.48 M-41.81%
2022ยฃ11.14 M-31.9%
2021ยฃ16.36 M-20.71%
2020ยฃ20.64 M303.63%
2019ยฃ5.11 M-70.5%
2018ยฃ17.33 M8.82%
2017ยฃ15.92 M-17.35%
2016ยฃ19.27 M-75.68%
2015ยฃ79.23 M19.37%
2014ยฃ66.37 M258.49%
2013ยฃ18.51 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
ยฃ37.69 Mยฃ0.11 B๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ56.63 Mยฃ0.12 B๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ0.21 Bยฃ0.39 B๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ8.79 Mยฃ70.41 M๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
ยฃ0.11 Bยฃ0.20 B๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ40.01 Mยฃ94.16 M๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ26.89 Mยฃ0.35 B๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
ยฃ0.29 Mยฃ1.23 M๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
N/Aยฃ0.04 M๐Ÿ‡บ๐Ÿ‡ธ USA